An Approach to Neurological Disorders in a Kidney Transplant Recipient

被引：9

作者：

Meena, Priti ^{[1
]}

Bhargava, Vinant ^{[1
]}

Rana, Devinder ^{[1
]}

Bhalla, Anil ^{[1
]}

Gupta, Ashwani ^{[1
]}

机构：

[1] Sir Ganga Ram Hosp, New Delhi 110092, India

来源：

KIDNEY360 | 2020年 / 1卷 / 08期

关键词：

ACUTE FEMORAL NEUROPATHY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVERSIBLE ENCEPHALOPATHY SYNDROME; RENAL-TRANSPLANTATION; COMPLICATIONS; CYCLOSPORINE; INFECTION; DISEASE; NEUROTOXICITY; MECHANISMS;

D O I：

10.34067/KID.0002052020

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Kidney transplantation is the preferred treatment modality in patients with ESKD. However, there are associated complications that arise from immunosuppressive medications, infections, and associated comorbidities. Neurologic disorders frequently develop in patients who have received a kidney transplant, which in turn increases the associated morbidity and mortality. This review discusses the common neurologic disorders after kidney transplantation, including infections, cognitive decline, drug-related conditions, malignancy, seizure, and other neurologic complications.

引用

收藏

页码：837 / 844

页数：8

相关论文

共 59 条

[1] Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside [J].

Aksamit, AJ .

JOURNAL OF NEUROVIROLOGY, 2001, 7 (04) :386-390

[2] Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies [J].

Al-Mansour, Zeina ;

Nelson, Beverly P. ;

Evens, Andrew M. .

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (03) :173-183

[3]

Anghel Daniela, 2013, Maedica (Bucur), V8, P170

[4]

[Anonymous], 2014, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States

[5] High level calcineurin activity predisposes neuronal cells to apoptosis [J].

Asai, A ;

Qiu, JH ;

Narita, Y ;

Chi, S ;

Saito, N ;

Shinoura, N ;

Hamada, H ;

Kuchino, Y ;

Kirino, T .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34450-34458

[6] Patients presenting with CNS lesions - Case 3. Sequential myeloproliferative disease and glioblastoma multiforme in a renal transplant recipient [J].

Au, WY ;

Hung, KN ;

Loong, F ;

Ma, SK .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :4062-4063

[7]

Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x

[8] Bortezomib-induced painful neuropathy in patients with multiple myeloma [J].

Bilinska, Malgorzata ;

Usnarska-Zubkiewicz, Lidia ;

Pokryszko-Dragan, Anna .

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05) :421-426

[9] Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression [J].

Caillard, S ;

Dharnidharka, V ;

Agodoa, L ;

Bohen, E ;

Abbott, K .

TRANSPLANTATION, 2005, 80 (09) :1233-1243

[10] Primary Central Nervous System Post-Transplantation Lymphoproliferative Disorder An International Primary Central Nervous System Lymphoma Collaborative Group Report [J].

Cavaliere, Robert ;

Petroni, Gina ;

Lopes, Maria B. ;

Schiff, David .

CANCER, 2010, 116 (04) :863-870

← 1 2 3 4 5 6 →